The US Food and Drug Administration (FDA) has approved an improved stool collection kit of Geneoscopy’s RNA-based colorectal ...

The earnings release highlighted strong GAAP revenue growth that beat consensus estimates, adjusted earnings per share (non-GAAP) that outpaced expectations, and an increase in adjusted operating ...

We primarily deployed the proceeds from selling Nilorn into Havas in the first quarter and into Fortrea during the second ...

Cost-Efficient Methodology Aims To Reduce Reliance On Expensive Diagnostic Procedures Such As MRI, CT Scans, PET Scans, and EchocardiogramsAPOLLO BEACH, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- ...

Looking back on testing & diagnostics services stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Labcorp (NYSE:LH) and its peers. The testing and diagnostics services ...

ATLAS trial investigator Guy Young, MD, Children's Hospital Los Angeles and University of Southern California Keck School of ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the testing & diagnostics ...

Raises Full-Year Guidance Financial results from Operations for second quarter 2025 versus second quarter 2024: Revenue: $3.53 billion versus $3.22 billion ...

Right now, Massachusetts hospitals are not required to give victims a drug test unless they've also been sexually assaulted. A bill being considered on Beacon Hill would change that, mandating ...

Quest Diagnostics has signed up to offer a blood test that can help diagnose Alzheimer’s disease, following its FDA clearance earlier this year. | The Lumipulse G blood test measures the ratio between ...